Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)

SHA:600276 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	412,521	291,858	287,598	245,741	323,076	591,745
Market Cap Growth	35.19%	1.48%	17.03%	-23.94%	-45.40%	53.53%
Enterprise Value	372,656	269,604	270,642	228,393	306,010	576,180
Last Close Price	62.08	45.73	44.85	38.07	49.91	91.20
PE Ratio	53.51	46.06	66.85	62.91	71.32	93.51
Forward PE	40.63	49.34	56.94	49.45	52.14	85.65
PS Ratio	13.31	10.43	12.60	11.55	12.47	21.34
PB Ratio	6.87	6.33	7.01	6.40	9.08	19.22
P/TBV Ratio	7.11	6.58	7.27	6.59	9.35	19.62
P/FCF Ratio	42.14	53.52	46.69	-	126.49	205.64
P/OCF Ratio	34.53	39.32	37.63	194.22	76.58	172.42
PEG Ratio	-	4.11	3.47	10.27	4.78	3.53
EV/Sales Ratio	12.03	9.63	11.86	10.74	11.81	20.78
EV/EBITDA Ratio	43.21	37.48	55.89	63.46	71.83	85.74
EV/EBIT Ratio	47.69	41.63	64.81	74.65	81.29	91.87
EV/FCF Ratio	38.07	49.44	43.94	-	119.81	200.23
Debt / Equity Ratio	0.00	0.00	0.00	0.04	0.00	-
Debt / EBITDA Ratio	0.01	0.02	0.02	0.37	0.04	-
Debt / FCF Ratio	0.01	0.02	0.01	-	0.06	-
Asset Turnover	0.53	0.60	0.53	0.52	0.70	0.89
Inventory Turnover	1.61	1.64	1.50	1.44	1.80	1.98
Quick Ratio	5.95	8.62	10.74	7.36	7.72	6.70
Current Ratio	6.55	9.72	12.25	8.50	8.88	7.44
Return on Equity (ROE)	14.34%	14.55%	10.77%	10.31%	13.51%	22.64%
Return on Assets (ROA)	8.37%	8.62%	6.06%	4.69%	6.36%	12.59%
Return on Capital (ROIC)	9.34%	9.27%	6.45%	5.07%	7.07%	14.07%
Return on Capital Employed (ROCE)	12.90%	13.90%	10.10%	7.90%	10.50%	20.30%
Earnings Yield	1.81%	2.17%	1.50%	1.59%	1.40%	1.07%
FCF Yield	2.37%	1.87%	2.14%	-0.30%	0.79%	0.49%
Dividend Yield	0.32%	0.44%	0.45%	0.42%	0.32%	0.18%
Payout Ratio	17.06%	20.12%	23.77%	26.00%	23.54%	16.07%
Buyback Yield / Dilution	-1.59%	-0.15%	1.20%	-0.36%	0.18%	0.03%
Total Shareholder Return	-1.27%	0.29%	1.65%	0.06%	0.50%	0.21%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.